Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11203298 | 0.88 | DDAH1 (0.51) | KDM4EKMT2AHTTAPEX1NPC1 | |
| Hydrochloric Acid SCHEMBL8829839 | 0.86 | HTR1A (0.49) | KDM4EKMT2AHTTAPEX1NPC1 | |
| SCHEMBL8906504 | 0.85 | L3MBTL1 (0.54) | KDM4EKMT2AHTTNPC1RAB9A | |
| SCHEMBL7996355 | 0.83 | SMN1; SMN2 (0.51) | KDM4EHTTRAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL15223716 | 0.82 | HTT (0.40) | KMT2AHTTAPEX1NPC1RAB9A | |
| SCHEMBL27639305 | 0.81 | F10 (0.57) | — | |
| SCHEMBL8788713 | 0.80 | APEX1 (0.56) | KMT2AAPEX1NPC1RAB9AALDH1A1 | |
| SCHEMBL6368877 | 0.79 | GAA (0.57) | KDM4EKMT2ANPC1RAB9AALDH1A1 | |
| SCHEMBL11887806 | 0.78 | APEX1 (0.64) | KDM4EKMT2AAPEX1NPC1RAB9A | |
| SCHEMBL7334277 | 0.78 | APEX1 (0.53) | APEX1ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009034029-A2 | 1-SUBSTITUTED 4-HETEROCYCLYLPIPERIDINES FOR USE AS CGRP ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-03-19 | — | — | WO | disclosed |